366 related articles for article (PubMed ID: 8889505)
1. Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas.
von Haken MS; White EC; Daneshvar-Shyesther L; Sih S; Choi E; Kalra R; Cogen PH
Genes Chromosomes Cancer; 1996 Sep; 17(1):37-44. PubMed ID: 8889505
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity on chromosome 22 in human ependymomas.
Huang B; Starostik P; Kühl J; Tonn JC; Roggendorf W
Acta Neuropathol; 2002 Apr; 103(4):415-20. PubMed ID: 11904762
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas.
Rubio MP; Correa KM; Ramesh V; MacCollin MM; Jacoby LB; von Deimling A; Gusella JF; Louis DN
Cancer Res; 1994 Jan; 54(1):45-7. PubMed ID: 8261460
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic alterations on chromosomes 11 and 22 in ependymomas.
Lamszus K; Lachenmayer L; Heinemann U; Kluwe L; Finckh U; Höppner W; Stavrou D; Fillbrandt R; Westphal M
Int J Cancer; 2001 Mar; 91(6):803-8. PubMed ID: 11275983
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas.
Ebert C; von Haken M; Meyer-Puttlitz B; Wiestler OD; Reifenberger G; Pietsch T; von Deimling A
Am J Pathol; 1999 Aug; 155(2):627-32. PubMed ID: 10433955
[TBL] [Abstract][Full Text] [Related]
6. Pediatric supratentorial ependymomas show more frequent deletions on chromosome 9 than infratentorial ependymomas: a microsatellite analysis.
Schneider D; Monoranu CM; Huang B; Rutkowski S; Gerber NU; Krauss J; Puppe B; Roggendorf W
Cancer Genet Cytogenet; 2009 Jun; 191(2):90-6. PubMed ID: 19446744
[TBL] [Abstract][Full Text] [Related]
7. Human ependymomas reveal frequent deletions on chromosomes 6 and 9.
Huang B; Starostik P; Schraut H; Krauss J; Sörensen N; Roggendorf W
Acta Neuropathol; 2003 Oct; 106(4):357-62. PubMed ID: 12898154
[TBL] [Abstract][Full Text] [Related]
8. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene?
Bruder CE; Ichimura K; Blennow E; Ikeuchi T; Yamaguchi T; Yuasa Y; Collins VP; Dumanski JP
Genes Chromosomes Cancer; 1999 Jun; 25(2):184-90. PubMed ID: 10338003
[TBL] [Abstract][Full Text] [Related]
9. Alterations of the TP53 gene in human gliomas.
Rasheed BK; McLendon RE; Herndon JE; Friedman HS; Friedman AH; Bigner DD; Bigner SH
Cancer Res; 1994 Mar; 54(5):1324-30. PubMed ID: 8118823
[TBL] [Abstract][Full Text] [Related]
10. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.
Singh PK; Gutmann DH; Fuller CE; Newsham IF; Perry A
Mod Pathol; 2002 May; 15(5):526-31. PubMed ID: 12011257
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity on 6q, 16q, and 17p in human central nervous system primitive neuroectodermal tumors.
Thomas GA; Raffel C
Cancer Res; 1991 Jan; 51(2):639-43. PubMed ID: 1670763
[TBL] [Abstract][Full Text] [Related]
12. Real-time quantitative PCR analysis of pediatric ependymomas identifies novel candidate genes including TPR at 1q25 and CHIBBY at 22q12-q13.
Karakoula K; Suarez-Merino B; Ward S; Phipps KP; Harkness W; Hayward R; Thompson D; Jacques TS; Harding B; Beck J; Thomas DG; Warr TJ
Genes Chromosomes Cancer; 2008 Nov; 47(11):1005-22. PubMed ID: 18663750
[TBL] [Abstract][Full Text] [Related]
13. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency.
Frankel RH; Bayona W; Koslow M; Newcomb EW
Cancer Res; 1992 Mar; 52(6):1427-33. PubMed ID: 1347252
[TBL] [Abstract][Full Text] [Related]
14. Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas.
Lomas J; Bello MJ; Arjona D; Alonso ME; Martinez-Glez V; Lopez-Marin I; Amiñoso C; de Campos JM; Isla A; Vaquero J; Rey JA
Genes Chromosomes Cancer; 2005 Mar; 42(3):314-9. PubMed ID: 15609345
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors.
Biegel JA; Burk CD; Barr FG; Emanuel BS
Cancer Res; 1992 Jun; 52(12):3391-5. PubMed ID: 1596898
[TBL] [Abstract][Full Text] [Related]
16. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM
Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216
[TBL] [Abstract][Full Text] [Related]
17. Deletion of chromosome arm 17p DNA sequences in pediatric high-grade and juvenile pilocytic astrocytomas.
Willert JR; Daneshvar L; Sheffield VC; Cogen PH
Genes Chromosomes Cancer; 1995 Mar; 12(3):165-72. PubMed ID: 7536455
[TBL] [Abstract][Full Text] [Related]
18. Correlation between 6q25.3 deletion status and survival in pediatric intracranial ependymomas.
Monoranu CM; Huang B; Zangen IL; Rutkowski S; Vince GH; Gerber NU; Puppe B; Roggendorf W
Cancer Genet Cytogenet; 2008 Apr; 182(1):18-26. PubMed ID: 18328946
[TBL] [Abstract][Full Text] [Related]
19. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.
Ueki K; Wen-Bin C; Narita Y; Asai A; Kirino T
Cancer Res; 1999 Dec; 59(23):5995-8. PubMed ID: 10606247
[TBL] [Abstract][Full Text] [Related]
20. Reduction to homozygosity and gene amplification in central nervous system primitive neuroectodermal tumors of childhood.
Raffel C; Gilles FE; Weinberg KI
Cancer Res; 1990 Feb; 50(3):587-91. PubMed ID: 1967549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]